[1]
Cheng, H.P. et al. 2021. USE OF SUBCUTANEOUS LONG-ACTING SOMATOSTATIN ANALOGUE OCTREOTIDE LAR IN A CHILD WITH CONGENITAL HYPERINSULINISM. Journal of the ASEAN Federation of Endocrine Societies. 36, (Jul. 2021), 69. DOI:https://doi.org/10.15605/jafes.036.S104.